Gastrointestinal hormones and regulation of food intake

被引:38
作者
Dhillo, WS [1 ]
Bloom, SR [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Dept Metab Med, London W12 0NN, England
关键词
ghrelin; cholecystokinin (cck); glucagon-like peptide-1 (7-36) amide (glp-1); oxyntomodulin; peptide YY (pyy); pancreatic polypeptide (pp); obesity;
D O I
10.1055/s-2004-826174
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity has been described as the greatest current threat to human health. In order to design drugs to target obesity, it is essential to understand its physiology and pathophysiology. Several peptides synthesised in the gastrointestinal tract which affect food intake have been identified including ghrelin, cholecystokinin (CCK), glucagon-like peptide-1 (7-36) amide (GLP-1), oxyntomodulin, peptide YY (PYY) and pancreatic polypeptide (PP). These peptides represent potential targets for the design of anti-obesity drugs. In this article we review recent advances in our understanding of food intake by these gastrointestinal hormones.
引用
收藏
页码:846 / 851
页数:6
相关论文
共 76 条
[1]   HUMAN DISTRIBUTION AND RELEASE OF A PUTATIVE NEW GUT HORMONE, PEPTIDE-YY [J].
ADRIAN, TE ;
FERRI, GL ;
BACARESEHAMILTON, AJ ;
FUESSL, HS ;
POLAK, JM ;
BLOOM, SR .
GASTROENTEROLOGY, 1985, 89 (05) :1070-1077
[2]   Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes [J].
Ahrén, B ;
Simonsson, E ;
Larsson, H ;
Landin-Olsson, M ;
Torgeirsson, H ;
Jansson, PA ;
Sandqvist, M ;
Båvenholm, P ;
Efendic, S ;
Eriksson, JW ;
Dickinson, S ;
Holmes, D .
DIABETES CARE, 2002, 25 (05) :869-875
[3]   AMP-activated protein kinase plays a role in the control of food intake [J].
Andersson, U ;
Filipsson, K ;
Abbott, CR ;
Woods, A ;
Smith, K ;
Bloom, SR ;
Carling, D ;
Small, CJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12005-12008
[4]   Other risk factors for pancreatic cancer:: Hormonal aspects [J].
Andrén-Sandberg, Å ;
Hoem, D ;
Bäckman, PL .
ANNALS OF ONCOLOGY, 1999, 10 :131-135
[5]   Characterization of the effects of pancreatic polypeptide in the regulation of energy balance [J].
Asakawa, A ;
Inui, A ;
Yuzuriha, H ;
Ueno, N ;
Katsuura, G ;
Fujimiya, M ;
Fujino, MA ;
Niijima, A ;
Meguid, MM ;
Kasuga, M .
GASTROENTEROLOGY, 2003, 124 (05) :1325-1336
[6]   Gut hormone PYY3-36 physiologically inhibits food intake [J].
Batterham, RL ;
Cowley, MA ;
Small, CJ ;
Herzog, H ;
Cohen, MA ;
Dakin, CL ;
Wren, AM ;
Brynes, AE ;
Low, MJ ;
Ghatei, MA ;
Cone, RD ;
Bloom, SR .
NATURE, 2002, 418 (6898) :650-654
[7]   Inhibition of food intake in obese subjects by peptide YY3-36 [J].
Batterham, RL ;
Cohen, MA ;
Ellis, SM ;
Le Roux, CW ;
Withers, DJ ;
Frost, GS ;
Ghatei, MA ;
Bloom, SR .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (10) :941-948
[8]   Pancreatic polypeptide reduces appetite and food intake in humans [J].
Batterham, RL ;
Le Roux, CW ;
Cohen, MA ;
Park, AJ ;
Ellis, SM ;
Patterson, M ;
Frost, GS ;
Ghatei, MA ;
Bloom, SR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (08) :3989-3992
[9]   Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans [J].
Beglinger, C ;
Degen, L ;
Matzinger, D ;
D'Amato, M ;
Drewe, J .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2001, 280 (04) :R1149-R1154
[10]   PANCREATIC-POLYPEPTIDE INFUSIONS REDUCE FOOD-INTAKE IN PRADER-WILLI SYNDROME [J].
BERNTSON, GG ;
ZIPF, WB ;
ODORISIO, TM ;
HOFFMAN, JA ;
CHANCE, RE .
PEPTIDES, 1993, 14 (03) :497-503